What next for Alzheimer's treatment?

Professor Selina Wray and Dr Ashvini Keshavan (UCL Queen Square Institute of Neurology) help examine the decisions of regulatory bodies to use Lecanemab and Donanemab in the NHS.

Listen: BBC Radio 4 ‘Inside Health’ (from 15 min, 16 sec)